Miglustat Dipharma 100 mg, capsule

7680676330026 CH-67633 Kapseln

Associated product:

MIGLUSTAT Dipharma caps 100 mg 84 pce
Miglustat Dipharma 100 mg, capsule
Miglustat Dipharma 100 mg, capsule
Miglustat Dipharma 100 mg, capsule
1 / 3
google

Article details

Package size
84
Selling units
84
Measure
Kapsel(n)
Galenic form
Kapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
04/04/2024
Patient information leaflet
Français
04/04/2024
Patient information leaflet
Italien
04/04/2024
Summary of Product Characteristics
Allemand
17/08/2023
Summary of Product Characteristics
Français
17/08/2023
Summary of Product Characteristics
Italien
17/08/2023

Detailed composition

Substance Quantity Type Category
(N/A)
100.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 4422.00
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/11/2020

Authorization holder

Dipharma SA

6830 Chiasso

Authorization information

Swissmedic authorization number
67633
Drug name
Miglustat Dipharma, capsule
Galenic form
KAHA
ATC Code
A16AX06
Authorization status
Z
Dispensing category
B
First authorization
03/04/2020
Authorization expiration date
31/12/9999
IT Number
07.99.0.
Domain
Human medicine

Package details

Description (FR)
MIGLUSTAT Dipharma caps 100 mg 84 pce
Description (DE)
MIGLUSTAT Dipharma Kaps 100 mg 84 Stk
Market launch
03/04/2020
Narcotic (BTM)
No

Original drug

Opfolda, Hartkapseln
GTIN: None
CHF 198.70
Not available in V1

Other package sizes (1)

MIGLUSTAT Dipharma caps 100 mg blist 84 pce
84 KAP
GTIN: 7680676330019
View